Abstract | STUDY OBJECTIVE: To evaluate whether the discontinuation of furosemide treatment resulted in a decrease in PaCO(2) and an increase in daytime and nocturnal oxygenation. BACKGROUND:
Furosemide is widely prescribed in patients with COPD for the treatment of peripheral edema. It is known that furosemide causes a metabolic alkalosis. A diminished chemoreceptor stimulation may cause a decreased alveolar ventilation. DESIGN: Randomized, double-blind, placebo-controlled, crossover trial. SETTING: Department of Pulmonology, Rijnstate Hospital Arnhem, the Netherlands. PATIENTS: Twenty patients with stable COPD (10 men; median age, 70 years [range, 58 to 81 years]; FEV(1) 35% predicted [range, 19 to 70% predicted]). Subjects were included if they had received furosemide, 40 mg/d, for the treatment of peripheral edema for at least a month and if they had a mean nocturnal arterial oxygen saturation (SaO(2)) < 92%. Patients with cardiac left and/or right ventricular dysfunction, sleep apneas, and patients receiving other diuretics, angiotensin-converting enzyme inhibitors, potassium or chloride replacement therapy, or long-term oxygen treatment were excluded. INTERVENTION:
Furosemide was discontinued for 1 week and replaced by placebo treatment in the first or the second week. MEASUREMENTS AND RESULTS: Ventilation, daytime arterial blood gas levels, and nocturnal SaO(2) were measured at baseline, after 1, and after 2 weeks. Sixteen subjects completed the study. Ventilation increased from 10.4 L/min (range, 6.7 to 15.4 L/min) at baseline to 11.6 L/min (range, 8.7 to 14.0 L/min) after discontinuation of furosemide (p < 0.05). PaCO(2) decreased from 45 mm Hg (range, 35 to 64 mm Hg) to 41 mm Hg (range, 32 to 61 mm Hg; p < 0.01). Daytime and nocturnal oxygenation did not improve. CONCLUSIONS: Although it does not improve oxygenation, the discontinuation of furosemide decreases PaCO(2) in patients with COPD.
|
Authors | Folkert Brijker, Yvonne F Heijdra, Frank J J van den Elshout, Hans Th M Folgering |
Journal | Chest
(Chest)
Vol. 121
Issue 2
Pg. 377-82
(Feb 2002)
ISSN: 0012-3692 [Print] United States |
PMID | 11834646
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Diuretics
- Furosemide
- Carbon Monoxide
|
Topics |
- Aged
- Aged, 80 and over
- Body Fluids
(metabolism)
- Carbon Monoxide
(analysis)
- Cross-Over Studies
- Diuretics
(pharmacology)
- Double-Blind Method
- Edema
(drug therapy)
- Female
- Furosemide
(pharmacology)
- Hemostasis
(drug effects)
- Humans
- Male
- Middle Aged
- Oxygen Consumption
(drug effects)
- Partial Pressure
- Pulmonary Disease, Chronic Obstructive
(physiopathology)
- Respiratory Function Tests
|